Project Grant HT9425261E161
Award Date 5/1/26
Completion Date 4/30/29
Dollars Obligated $750K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Irvine, CA 92697, USA
Similar Awards
- Federal Grant Award Summary The University of California, Irvine received a $559,976 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2026 through August 31, 2028. The award supports research targeting mechanosensing PIEZO1 channels in CD8 T cells to enhance melanoma tumor immunity. This research initiative represents a translational effort to develop innovative immunotherapeutic approaches for...
- Federal Project Grant Award Summary The University of California, Davis received a $481,056 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the period of September 30, 2025 through September 29, 2027. The award supports research investigating ARHGEF2 in promoting neural lineage plasticity and treatment resistance in advanced prostate cancer. This research aligns with the program's focus on transforming healthcare for...
- Federal Project Grant Award Summary The University of California, San Francisco (UCSF) received a $750,000 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded March 1, 2026, with completion scheduled for February 28, 2029. This three-year award supports research and development activities focused on the use of dimeric immunoglobulin A as a therapeutic approach to treat breast cancer. The research will be...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded a $235,476 project grant to the University of California, Los Angeles (UCLA) Office of Research Administration on November 1, 2025, to develop new cell-mediated immunotherapeutic strategies for neuroendocrine prostate cancer. The two-year award, which concludes October 31, 2027, is funded under the Military Medical Research and Development program (CFDA 12.420) and will be conducted at UCLA's Los Angeles, California facility....
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded UC San Diego a $1.65 million project grant under the Military Medical Research and Development program (CFDA 12.420) effective May 1, 2026, through April 30, 2029. The award supports research focused on targeting oncoembryonic antigens to overcome therapy resistance in patients with triple-negative breast cancer. This research initiative represents a translational oncology effort within the DHA's broader portfolio of...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded University of California, Davis $1,729,963 under the Military Medical Research and Development program (CFDA 12.420) to support research on novel therapeutics targeting bromodomain and extraterminal domain (BET)-mediated oncogenesis in lethal prostate cancer. The award, effective November 1, 2025, through October 31, 2028, funds hypothesis-driven biomedical research designed to develop innovative therapeutic solutions addressing...
- Federal Project Grant Award Summary The University of California, San Francisco (UCSF) received a $1.62M project grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) awarded June 1, 2026, for a three-year performance period concluding May 31, 2029. The award supports research and development activities focused on novel mitochondrial metabolism inhibitors targeting aggressive and treatment-resistant MYC-high breast cancers. This research...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded the University of California, Los Angeles (UCLA) a $590,625 project grant effective September 1, 2025, through August 31, 2028, under the Military Medical Research and Development program (CFDA 12.420). The grant funds a pilot study investigating dual immunotherapy targeting PD-1 (programmed death receptor 1) and CD73 in combination with chemotherapy for patients with pancreatic adenocarcinoma, with specific focus on...
- Federal Project Grant Award Summary The University of California, Irvine received a $785,000 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), effective June 15, 2025, with a completion date of June 14, 2028. The research project investigates an endocannabinoid deficit in brain neuroinflammatory control as a therapeutic target for Gulf War Illness. This three-year funded initiative supports hypothesis-driven biomedical...
- Federal Grant Award Summary The University of California, San Francisco (UCSF) received a $1,594,419 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the project "Radiopathomic Mapping of Tumor Burden for Personalized Management of IDH-Mutant Glioma." The award, effective September 1, 2025, through August 31, 2028, supports advanced biomedical research focused on developing innovative diagnostic and...